Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
McKesson
Moodys
Harvard Business School
Merck

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Halcinonide - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for halcinonide and what is the scope of freedom to operate?

Halcinonide is the generic ingredient in three branded drugs marketed by Mylan, Sun Pharm Inds Inc, Westwood Squibb, and Bristol Myers Squibb, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for halcinonide. Three suppliers are listed for this compound.

Summary for halcinonide
Pharmacology for halcinonide
Medical Subject Heading (MeSH) Categories for halcinonide
Synonyms for halcinonide
(11?,16?)-21-Chloro-9-fluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-pregn-4-ene-3,20-dione
(11|A,16|A)-21-Chloro-9-fluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]pregn-4-ene-3,20-dione
(4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS)-6b-(chloroacetyl)-4b-fluoro-5-hydroxy-4a,6a,8,8-tetramethyl-3,4,4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-tetradecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
093H354
21-Chloro-9-fluoro-11beta,16alpha,17-trihydroxypregn-4-ene-3,20-dione cyclic 16,17-acetal with acetone
3093-35-4
5-19-06-00301 (Beilstein Handbook Reference)
AC-1114
AC-1774
AC1L9FG3
Adcortin
AKOS015962797
Alcinonide
AN-14636
Ascochrom
BC214763
Betacorton
BPBio1_000759
BRD-K81709173-001-03-8
BRN 1358242
BSPBio_000689
C24H32ClFO5
CAS-3093-35-4
CCG-220655
CHEBI:31663
CHEMBL1200845
D01308
DB06786
DSSTox_CID_25375
DSSTox_GSID_45375
DSSTox_RID_80836
DTXSID6045375
EINECS 221-439-6
Halciderm
Halcimat
Halcinonid
Halcinonida
Halcinonida [INN-Spanish]
Halcinonide (JAN/USP/INN)
Halcinonide [USAN:USP:INN:BAN:JAN]
Halcinonide, United States Pharmacopeia (USP) Reference Standard
Halcinonidum
Halcinonidum [INN-Latin]
Halcort
Halog
Halog (TN)
HALOG-E
HMS1570C11
HMS2097C11
HMS2230O07
HMS3714C11
HY-B0877
MLS002153935
MolPort-005-937-976
NCGC00016621-01
NCGC00179475-01
NCGC00179475-03
P753
Pregn-4-ene-3,20-dione, 21-chloro-9-fluoro-11-beta,16-alpha,17-trihydroxy-, cyclic16,17-acetal with acetone
Pregn-4-ene-3,20-dione, 21-chloro-9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-, (11beta,16alpha)-
Prestwick_1069
Prestwick0_000655
Prestwick1_000655
Prestwick2_000655
Prestwick3_000655
Q-201180
s4098
SC-80633
SCHEMBL4335
SI86V6QNEG
SMR001233277
SO-18566
SPBio_002610
SQ 18566
SQ-18,566
SQ-18566
Tox21_110530
Tox21_110530_1
UNII-SI86V6QNEG
Volog
ZINC4213474

US Patents and Regulatory Information for halcinonide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan HALCINONIDE halcinonide CREAM;TOPICAL 211027-001 Aug 12, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Sun Pharm Inds Inc HALOG-E halcinonide CREAM;TOPICAL 018234-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Westwood Squibb HALOG halcinonide CREAM;TOPICAL 017818-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Sun Pharm Inds Inc HALOG halcinonide SOLUTION;TOPICAL 017823-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Sun Pharm Inds Inc HALOG halcinonide CREAM;TOPICAL 017556-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Sun Pharm Inds Inc HALOG halcinonide OINTMENT;TOPICAL 017824-001 Approved Prior to Jan 1, 1982 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Colorcon
Harvard Business School
Mallinckrodt
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.